NSF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.333800E-01
Normal-vs-Stage2
9.382400E-01
Normal-vs-Stage3
1.085650E-01
Normal-vs-Stage4
5.091800E-01
Stage1-vs-Stage2
5.855900E-02
Stage1-vs-Stage3
4.597900E-03
Stage1-vs-Stage4
4.380600E-01
Stage2-vs-Stage3
3.109900E-02
Stage2-vs-Stage4
4.063200E-01
Stage3-vs-Stage4
1.379950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.464400E-01
Normal-vs-AfricanAmerican
6.023400E-01
Normal-vs-Asian
8.567000E-01
Caucasian-vs-AfricanAmerican
5.231000E-01
Caucasian-vs-Asian
6.982000E-01
AfricanAmerican-vs-Asian
3.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.257400E-01
Normal-vs-Female
9.268400E-01
Male-vs-Female
9.590200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.299200E-01
Normal-vs-Age(41-60Yrs)
6.122400E-01
Normal-vs-Age(61-80Yrs)
8.730000E-01
Normal-vs-Age(81-100Yrs)
7.836200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.275000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.139000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.463800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.759720E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.979800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.438600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.521800E-01
Normal-vs-Daily Drinker
3.627800E-01
Normal-vs-Weekly Drinker
4.250800E-01
Normal-vs-Occasional Drinker
3.581600E-01
Normal-vs-Social Drinker
7.709600E-01
Non Drinker-vs-Daily Drinker
8.689800E-01
Non Drinker-vs-Weekly Drinker
9.371800E-01
Non Drinker-vs-Occasional Drinker
3.517000E-03
Non Drinker-vs-Social Drinker
1.870380E-01
Daily Drinker-vs-Weekly Drinker
9.501600E-01
Daily Drinker-vs-Occasional Drinker
2.759200E-03
Daily Drinker-vs-Social Drinker
1.671040E-01
Weekly Drinker-vs-Occasional Drinker
4.681300E-03
Weekly Drinker-vs-Social Drinker
1.863850E-01
Occasional Drinker-vs-Social Drinker
4.641400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.324590E-01
Normal-vs-Grade 2
3.418200E-02
Normal-vs-Grade 3
2.132100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.722000E-02
Grade 1-vs-Grade 3
9.234100E-02
Grade 1-vs-Grade 4
1.324590E-01
Grade 2-vs-Grade 3
9.020400E-01
Grade 2-vs-Grade 4
3.418200E-02
Grade 3-vs-Grade 4
2.132100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.085800E-01
Normal-vs-NonDiabetic
9.621400E-01
Diabetic-vs-NonDiabetic
2.035200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.318600E-01
Normal-vs-NoPancreatitis
9.710600E-01
Pancreatitis-vs-NoPancreatitis
6.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.722000E-01
Normal-vs-N1
9.442200E-01
N0-vs-N1
2.057400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.857800E-01
Normal-vs-TP53-NonMutant
5.825200E-01
TP53-Mutant-vs-TP53-NonMutant
2.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
